Gang Chen

ORCID: 0000-0003-3332-3511
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Extracellular vesicles in disease
  • MicroRNA in disease regulation
  • RNA Interference and Gene Delivery
  • Vascular Malformations and Hemangiomas
  • Nanoplatforms for cancer theranostics
  • Immune cells in cancer
  • Cancer Immunotherapy and Biomarkers
  • Advanced biosensing and bioanalysis techniques
  • Cancer-related molecular mechanisms research
  • Phagocytosis and Immune Regulation
  • Immunotherapy and Immune Responses
  • Microfluidic and Bio-sensing Technologies
  • Vascular Malformations Diagnosis and Treatment
  • Circular RNAs in diseases
  • Nanopore and Nanochannel Transport Studies
  • RNA modifications and cancer
  • Oral and Maxillofacial Pathology
  • Cancer, Hypoxia, and Metabolism
  • Ferroptosis and cancer prognosis
  • Cell Adhesion Molecules Research
  • Autophagy in Disease and Therapy
  • Salivary Gland Disorders and Functions
  • 3D Printing in Biomedical Research
  • Cancer Cells and Metastasis
  • Rhetoric and Communication Studies

Wuhan University
2016-2025

Harbin Medical University
2025

Fourth Affiliated Hospital of Harbin Medical University
2025

First Affiliated Hospital of GuangXi Medical University
2022-2024

Guangxi Medical University
2022-2024

Zhengzhou University of Light Industry
2023-2024

Huazhong Agricultural University
2023

Wenzhou Medical University
2017-2023

Affiliated Eye Hospital of Wenzhou Medical College
2023

Jiaxing University
2022-2023

Abstract Anti-PD-1/PD-L1 immunotherapy has achieved impressive therapeutic outcomes in patients with multiple cancer types. However, the underlined molecular mechanism(s) for moderate response rate (15–25%) or resistance to PD-1/PD-L1 blockade remains not completely understood. Here, we report that inhibiting deubiquitinase, USP8, significantly enhances efficacy of anti-PD-1/PD-L1 through reshaping an inflamed tumor microenvironment (TME). Mechanistically, USP8 inhibition increases PD-L1...

10.1038/s41467-022-29401-6 article EN cc-by Nature Communications 2022-03-31

Cell-derived microvesicles (MVs) are natural carriers that can transport biological molecules between cells, which expected to be promising delivery vehicles for therapeutic purposes. Strategies label MVs very important investigation and application of MVs. Herein, ultrasmall Mn-magnetofunctionalized Ag2Se quantum dots (Ag2Se@Mn QDs) integrated with excellent near-infrared (NIR) fluorescence magnetic resonance (MR) imaging capabilities have been developed instant efficient labeling their in...

10.1021/jacs.5b10340 article EN Journal of the American Chemical Society 2016-01-23

Cell-derived microvesicles (MVs), which are biogenic nanosized membrane-bound vesicles that convey bioactive molecules between cells, have recently received attention for use as natural therapeutic platforms. However, the medical applications of MV-based delivery platforms limited by lack effective methods efficient isolation MVs and convenient tuning their targeting properties. Herein, we report development magnetic folate (FA)-modified based on a donor cell-assisted membrane modification...

10.1021/acsnano.6b05630 article EN ACS Nano 2016-12-24

Nickel compounds are carcinogenic to humans, possibly through induction of reactive oxygen species (ROS) that damage macromolecules including DNA and proteins. The aim the present study is elucidate role ROS-mediated Akt/apoptosis-regulating signal kinase (ASK) 1/p38 pathway in nickel-induced apoptosis. Exposure human bronchial epithelial cells (BEAS-2B) nickel induced generation ROS activation Akt associated with ASK1 p38 mitogen-activated protein kinase. Immunoblotting suggested a...

10.1021/tx9003193 article EN publisher-specific-oa Chemical Research in Toxicology 2010-01-29

Resistance to chemotherapy remains a major obstacle for the effective treatment of oral squamous cell carcinoma (OSCC). Evidence involvement exosomes as important regulators cisplatin chemoresistance in OSCC is still poorly understood. Our objective this study was explore roles modulating key cellular pathways mediating response chemotherapy. We first developed cisplatin-resistant lines (HSC-3-R and SCC-9-R) found that conditioned media from cells enhanced parental cell. The release blocked...

10.1093/abbs/gmx078 article EN Acta Biochimica et Biophysica Sinica 2017-07-10

Many cancers including head and neck squamous cell carcinoma (HNSCC) are characterized by a metabolic rewiring with increased glucose uptake lactate production, termed as aerobic glycolysis. Targeting glycolysis presents promising strategy for cancer therapy. This study investigates the therapeutic potential of blockage targeting phosphofructokinase-2/fructose-2, 6-bisphosphatase 3 (PFKFB3) in HNSCC. 1-(4-pyridinyl)-3-(2-quinolinyl)-2-propen-1-one (PFK15) was used selective antagonist...

10.1186/s13046-016-0481-1 article EN cc-by Journal of Experimental & Clinical Cancer Research 2017-01-06

Abstract Hepatoblastoma is the most common liver tumor of early childhood, which usually characterized by unusual hypervascularity. Recently, long non-coding RNAs (lncRNA) have emerged as gene regulators and prognostic markers in several cancers, including hepatoblastoma. We previously reveal that lnRNA-TUG1 upregulated hepatoblastoma specimens microarray analysis. In this study, we aim to elucidate biological clinical significance TUG1 upregulation show significantly human metastatic cell...

10.1038/cddis.2016.143 article EN cc-by Cell Death and Disease 2016-06-30

Central nervous system (CNS) injuries, including stroke, traumatic brain injury, and spinal cord are essential causes of death long-term disability difficult to cure, mainly due the limited neuron regeneration glial scar formation. Herein, we apply extracellular vesicles (EVs) secreted by M2 microglia improve differentiation neural stem cells (NSCs) at injured site, simultaneously modify them with vascular targeting peptide (DA7R) cell recruiting factor (SDF-1) on their surface via...

10.1016/j.apsb.2022.06.007 article EN cc-by-nc-nd Acta Pharmaceutica Sinica B 2022-06-10

Bleomycin (BLM), one of the most common sclerosants, is often used to treat venous malformations (VMs). The present study was designed investigate whether endothelial mesenchymal transition (EndoMT) contributes therapeutic effects BLM.Endothelial and markers HUVECs were measured by immunofluorescence, real-time quantitative PCR Western blot analysis. Cell migration tube formation assays performed evaluate cell function. Slug small-interfering RNA specific inhibitors [Z-VAD-FMK for pan...

10.1111/bph.12355 article EN British Journal of Pharmacology 2013-08-29

Extracellular vesicles (EVs) are cell-derived membrane-enclosed structures that deliver biomolecules for intercellular communication. Developing visualization methods to elucidate the spatiotemporal dynamics of EVs' behaviors will facilitate their understanding and translation. With a quantum dot (QD) labeling strategy, single particle tracking (SPT) platform is proposed here dissecting dynamic EVs. The interplays between tumor small EVs (T-sEVs) endothelial cells (ECs) specifically...

10.1002/advs.202205566 article EN cc-by Advanced Science 2023-01-04

Abstract Only a minority of cancer patients benefit from immune checkpoint blockade therapy. Sophisticated cross-talk among different pathways as well interaction pattern molecules carried on circulating small extracellular vesicles (sEV) might contribute to the low response rate. Here we demonstrate that PD-1 and CD80 immunocyte-derived sEVs (I-sEV) induce an adaptive redistribution PD-L1 in tumour cells. The resulting decreased cell membrane expression increased sEV secretion into...

10.1038/s41467-024-48200-9 article EN cc-by Nature Communications 2024-05-08

Liquid biopsy is of great significance in tumor early diagnosis and treatment stratification. PD-L1-positive small extracellular vesicles (PD-L1+ sEVs) are closely related to growth immunotherapy response, which considered valuable liquid biomarkers. In contrast conventional vitro detection, vivo detection has the ability improve efficiency enable continuous or real-time dynamic monitoring. However, PD-L1+ sEVs multiple difficulties, such as high cell background, complex blood environments,...

10.1021/acs.analchem.3c05418 article EN Analytical Chemistry 2024-02-05
Coming Soon ...